What does CUSIP 53619R102 represent in this 13F holders report?

CUSIP 53619R102 is the security identifier for LBIO - LION BIOTECHNOLOGIES INC - COM used to aggregate holder disclosures.

How many institutions held LBIO - LION BIOTECHNOLOGIES INC - COM in Q1 2017?

79 institutional investors reported LBIO - LION BIOTECHNOLOGIES INC - COM for Q1 2017. Use the holders table for investor-level position and value details.

LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / COM
Total 13F shares: 48,530,675
Share change: +4,914,877
Total reported value: $361,235,782
Put/Call ratio: 13%
Price per share: $7.45
Number of holders: 79
Value change: +$36,798,947
Number of buys: 35
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 53619R102:

Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q1 2017

As of 31 Mar 2017, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,530,675 shares. The largest 10 holders included BlackRock Inc., FRANKLIN RESOURCES INC, venBio Select Advisor LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, ACUTA CAPITAL PARTNERS, LLC, ORBIMED ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, and VANGUARD GROUP INC. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.